Ceres Medical

Ceres Nanosciences is a life sciences company that develops and commercializes innovative sample preparation products based on its proprietary Nanotrap particle technology. The Nanotrap particles are designed to capture, concentrate, and preserve low-abundance analytes from complex biological samples, significantly improving the sensitivity of diagnostic tests. The company's technology has been applied to various areas, including infectious diseases like COVID-19 and Lyme disease, as well as oncology and point-of-care diagnostics. Ceres Nanosciences has received significant funding from the NIH and other organizations to expand its manufacturing capacity and develop new diagnostic applications.